Kabuki syndrome CRIPSR/Cas9 KMT2D
Showing 1 - 25 of >10,000
Gene Editing as a Therapeutic Approach for Rett Syndrome
Recruiting
- Rett Syndrome
- Gene editing in vitro
-
Siena, ItalyUniversity of Siena
Feb 13, 2023
Exploiting Epigenome Editing in Kabuki Syndrome:New Route
Completed
- Kabuki Syndrome 1
- Intervention on primary cultured cells
-
Montpellier, Herault, FranceArnaud de villeneuve Hospital
Nov 30, 2020
People Who Have Genetic Changes and Features of Autism: Simons
Recruiting
- 16P11.2 Deletion Syndrome
- +184 more
-
New York, New York
- +1 more
Jan 6, 2023
Kabuki Syndrome Trial in Baltimore (Modified Atkins diet)
Recruiting
- Kabuki Syndrome
- Modified Atkins diet
-
Baltimore, MarylandKennedy Krieger Institute
Nov 17, 2022
Non-hodgkin Lymphoma,B Cell Trial in Beijing (Autologous CD19-STAR-T cell, Fludarabine, Cyclophosphamide)
Recruiting
- Non-hodgkin Lymphoma,B Cell
- Autologous CD19-STAR-T cell
- +2 more
-
Beijing, Beijing, China
- +1 more
Nov 21, 2022
Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Nashville (CTX001)
Recruiting
- Beta-Thalassemia
- +4 more
- CTX001
-
Nashville, Tennessee
- +5 more
Feb 2, 2023
Sickle Cell Disease, Hydroxyurea Failure, Hydroxyurea Intolerance Trial in Nashville (CTX001)
Recruiting
- Sickle Cell Disease
- +4 more
- CTX001
-
Philadelphia, Pennsylvania
- +3 more
Jan 24, 2023
Hyperperfusion After Carotid Stenting by Multi-parameter
Enrolling by invitation
- Cerebral Artery Stenosis
- +2 more
- carotid artery stenting
-
Beijing, Beijing, ChinaDepartment of Vascular Ultrasonography, Xuanwu Hospital of Capit
Sep 21, 2023
Carbapenem-Resistant Enterobacteriaceae Infection Trial in Jinan (CAZ/AVI plus Aztreonam, Conventional treatment)
Recruiting
- Carbapenem-Resistant Enterobacteriaceae Infection
- CAZ/AVI plus Aztreonam
- Conventional treatment
-
Jinan, Shandong, ChinaMingju Hao
Apr 29, 2023
Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Worldwide (CTX001)
Active, not recruiting
- Beta-Thalassemia
- +4 more
- CTX001
-
Stanford, California
- +11 more
Nov 30, 2022
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22);
Completed
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +10 more
- Erlotinib Hydrochloride
- Laboratory Biomarker Analysis
-
Houston, TexasM D Anderson Cancer Center
Dec 18, 2019
Immune Thrombocytopenia, Autoimmune Hemolytic Anemia, Evans Syndrome Trial in France (data collection)
Recruiting
- Immune Thrombocytopenia
- +2 more
- data collection
-
Amiens, France
- +8 more
Jul 7, 2023
Viral Keratitis, Blindness Eye, Herpes Simplex Virus Infection Trial in Shanghai (BD111 Adult single group Dose)
Completed
- Viral Keratitis
- +3 more
- BD111 Adult single group Dose
-
Shanghai, Shanghai, ChinaEye & Ent Hospital of Fudan University
Aug 20, 2022
Beta-Thalassemia, Thalassemia, Hematologic Diseases Trial (CTX001)
Not yet recruiting
- Beta-Thalassemia
- +6 more
- CTX001
- (no location specified)
Jul 26, 2022
Transfusion Dependent Beta-Thalassaemia Trial in Guangzhou, Shenzhen, Tianjin (ET-01)
Active, not recruiting
- Transfusion Dependent Beta-Thalassaemia
- ET-01
-
Guangzhou, Guangdong, China
- +3 more
May 9, 2022
Rett Syndrome Trial in Verona (Osteopathic manipulative treatment)
Completed
- Rett Syndrome
- Osteopathic manipulative treatment
-
Verona, ItalyCentro AIRETT Ricerca e Innovazione (CARI)
Jan 30, 2023
CSVD Burden in Carotid Artery Stenosis
Recruiting
- Carotid Artery Stenosis
- Cerebral Small Vessel Diseases
- carotid artery stenting
-
Hangzhou, Zhejiang, ChinaZhejiang Provincial People's Hospital
Sep 4, 2023
CTEPH Trial in Fukuoka (Edoxaban, Warfarin Potassium, Warfarin Potassium )
Active, not recruiting
- CTEPH
- Edoxaban
- +3 more
-
Fukuoka, JapanKyushu University Hospital
Aug 30, 2022
Non Hodgkin's Lymphoma Trial in Beijing (TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T),
Not yet recruiting
- Non Hodgkin's Lymphoma
- TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T)
- +2 more
-
Beijing, China
- +2 more
Aug 23, 2023
Acute Myelocytic Leukemia, Myelodysplastic Syndrome Trial in Germany (Azacitidine)
Completed
- Acute Myelocytic Leukemia
- Myelodysplastic Syndrome
-
Berlin, Germany
- +10 more
Nov 12, 2021
Stem Cells in NF1 Tumors of the Central Nervous System
Suspended
- Neurofibromatosis Type 1
- Tumors of the Central Nervous System
- Collection of Stem Cells
-
Washington, District of ColumbiaChildren's National Medical Center
Mar 8, 2022
Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy
Recruiting
- DLBCL
- +8 more
- Cardiac MRI
-
Bonn, NRW, GermanyUniversity Hospital Bonn
Jun 11, 2022
Anxiety, Depression Trial (Metacognitive Therapy)
Not yet recruiting
- Anxiety
- Depression
- Metacognitive Therapy
- (no location specified)
Aug 4, 2023